Founded in 2005, BRL Trust grew quickly. At that time their activities provided trust services in private loans. At the end of their first year, the company had more than loans in which the Trust acted as an intervening trust. Their customers quickly learned to trust the new company and were soon demanding that the Trust expand and diversify. These demands soon led to new business areas such as Administrative Management of investment funds as well as mergers and acquisitions.
The group has gained this trust by staying focused on their mission and values statements. They define their mission as meeting the demands of their customers in a safe and efficient manner while maintaining transparency with a skilled and experienced team. Further, they state that their main differential processes and controls be unique and internally developed from knowledge acquired from its performance sector. As far as values they state that ethics in all situations must be addressed respecting national legal systems and the interest of clients as more important than their personal gain. They further believe that determination and discipline is a valuable characteristic of their team members.
Newsgroups including the LA Times, GeoPlay International and Dragon Capital are all very taken with the group who now works with clients globally. The trust does so while maintaining strict adherence to skillfully finding unique solutions that remain legal to the various nations served. Other benefits include a belief that all customers are unique. That relationship-building is vital to their success. The trust feels that all activities must be monitored and authorized by a securities commission to make sure that all legalities are addressed. They even have the policy to help stop money laundering. It’s these qualities that have set BRL apart from other trusts, making them one of the largest and most trusted companies in their industry.
Sun Bin’s parents have spent the last 24 years wondering about their son. Was he okay? Is he happy, healthy, still alive? That’s because in 1991 4 year old Sun Bin was abducted from a vegetable market in his home town of Sichuan province. His parents had no idea that he was taken and sold to a family thousands of miles way in the Jiangsu province. According to the story on CNN.com it is common that young boys are abducted and sold in China since boys are prized and can be sold for more money.
Sun Bin and his father were reunited at a Chengdu police station earlier this week after a DNA test proved to be a match. Unfortunately Sun Bin’s mother passed away in 2011 but she never forgot him. The elder Sun said she died saying his name and wished for him to be found.
How heartbreaking. Losing your child for so long, not knowing what happened. It is a shame that Sun Bin’s mother did not live to see her son return. I cannot imagine what other parents in China must feel like losing their children to traffickers. Rod Rohrich is happy to see this family reunite, he mentions this in this article on plasticsurgery.org
Mark Ahn & the secret to biotech industry success
PR Newswire first published this account of a conversation with Dr. Mark Ahn at Pukana Partners on biotech startups. Dr. Ahn has done a great deal of work on the biotech startup field, and he has advice for anyone who wants to dive into that arena.
Get Your Own Business Plan
The business plan for a biotech startup is different than the business plan for any other company. These companies has to wait months or even years to get certain products ready to sell, and they need to be flexible in the ways that they will make money.
Agree On The Plan
Many management teams and boards of directors have a hard time agreeing on the plan that must be used to propel the business forward. This is an issue for anyone who wants to have a successful business, and arguing needs to be kept to a minimum.
He knows how the startups work in this industry, and he has done the research that shows that these businesses only succeed under parameters he has studied.
See original post: Mark Ahn Explains Why Some Biotech Startups Succeed, While Others Wither